A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-11

  Bernthal, Nicholas M ^a   Stavrakis, Alexandra I ^a   Billi, Fabrizio ^a   Cho, John S ^a   Kremen, Thomas J ^a   Simon, Scott I ^b   Cheung, Ambrose L ^c   Finerman, Gerald A ^a   Lieberman, Jay R ^d   Adams, John S ^a   Miller, Lloyd S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; POLYMER; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPLASTY; ARTICLE; BACTERIAL COUNT; BIOFILM; BIOLUMINESCENCE; CONTROLLED STUDY; DEFIBRILLATOR; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EX VIVO STUDY; FLUORESCENCE; IMAGING AND DISPLAY; IMPLANTATION; IN VIVO STUDY; INFECTIOUS ARTHRITIS; INOCULATION; KNEE; LEG EDEMA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ANIMAL; ARTHROPATHY; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; JOINT; MICROBIOLOGY; MOUSE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROSTHESES AND ORTHOSES; STAPHYLOCOCCUS INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; DISEASE MODELS, ANIMAL; HUMANS; JOINT DISEASES; JOINTS; MALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77958516998     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012580     Document Type: Article

References (63)

1. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, et al. (2008) Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 23: 984-991.
2. Bozic KJ, Ries MD (2005) The impact of infection after total hip arthroplasty onhospital and surgeon resource utilization. J Bone Joint Surg Am 87: 1746-1751.
3. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, et al. (2009) Incidence and Risk Factors for Deep Surgical Site Infection After Primary Total Hip Arthroplasty: A Systematic Review. J Arthroplasty; S0883-5403(09)00411-2 [pii];10.1016/j.arth.2009.08.011 [doi].
4. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, et al. (2010) The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 468: 45-51.10.1007/s11999-009-0945-0 [doi].
5. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, et al. (2009) The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 91: 128-133. 91/1/128 [pii];10.2106/JBJS.H.00155 [doi].
6. Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89: 780-785.
7. Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, et al. (2007) Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 89 Suppl 3: 144-151.
8. Del Pozo JL, Patel R (2009) Clinical practice. Infection associated with prosthetic joints. N Engl J Med 361: 787-794. 361/8/787 [pii];10.1056/NEJMcp0905029 [doi].
9. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351: 1645-1654.
10. Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350: 1422-1429.
11. Trampuz A, Widmer AF (2006) Infections associated with orthopedic implants. Curr Opin Infect Dis 19: 349-356.
12. Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, et al. (2006) Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 88: 1231-1237.
13. Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461: 48-53.
14. Walls RJ, Roche SJ, O'Rourke A, McCabe JP (2008) Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg Br 90: 292-298.
15. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466: 1710-1715.
16. Chiu FY, Lin CF (2009) Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am 91: 628-633. 91/3/628 [pii];10.2106/JBJS.G.01570 [doi].
17. Diwanji SR, Kong IK, Park YH, Cho SG, Song EK, et al. (2008) Two-stage reconstruction of infected hip joints. J Arthroplasty 23: 656-661.S0883-5403(07)00360-9 [pii];10.1016/j.arth.2007.06.007 [doi].
18. Toulson C, Walcott-Sapp S, Hur J, Salvati E, Bostrom M, et al. (2009) Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol: update on ''our institution's'' experience from 1989 to 2003. J Arthroplasty 24: 1051-1060.S0883-5403(08)00612-8 [pii];10.1016/j.arth.2008.07.004 [doi].
19. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ (2007) Antibioticimpregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am 89: 871-882.
20. Jiranek WA, Hanssen AD, Greenwald AS (2006) Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 88: 2487-2500.
21. Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, et al. (2007) Twostage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 89: 1227-1231.
22. Sierra RJ, Trousdale RT, Pagnano MW (2003) Above-the-knee amputation after a total knee replacement: prevalence, etiology, and functional outcome. J Bone Joint Surg Am 85-A: 1000-1004.
23. Conway JD, Mont MA, Bezwada HP (2004) Arthrodesis of the knee. J Bone Joint Surg Am 86-A: 835-848.
24. Bargiotas K, Wohlrab D, Sewecke JJ, Lavinge G, DeMeo PJ, et al. (2007) Arthrodesis of the knee with a long intramedullary nail following the failure of a total knee arthroplasty as the result of infection. Surgical technique. J Bone Joint Surg Am 89 Suppl 2 Pt.1: 103-110. 89/2_suppl_1/103 [pii];10.2106/JBJS.F.01125 [doi].
25. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS (2004) Surgicalsite infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 25: 461-467.
26. Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, et al. (2006) Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am. 88, 88: 1705-1712. 88/8/1705[pii];10.2106/JBJS.E.01156 [doi].
27. Hetrick EM, Schoenfisch MH (2006) Reducing implant-related infections: active release strategies. Chem Soc Rev 35: 780-789. 10.1039/b515219b [doi].
28. Campoccia D, Montanaro L, Arciola CR (2006) The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27: 2331-2339. S0142-9612(05)01093-8 [pii];10.1016/j.biomaterials.2005.11.044 [doi].
29. Zhao L, Chu PK, Zhang Y, Wu Z (2009) Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 91: 470-480. 10.1002/jbm.b.31463 [doi].
30. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138. S0140673601053211 [pii].
31. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
32. Fitzgerald RH, Jr. (1983) Experimental osteomyelitis: description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis. J Bone Joint Surg Am 65: 371-380.
33. Marcellin-Little DJ, Papich MG, Richardson DC, DeYoung DJ (1996) Pharmacokinetic model for cefazolin distribution during total hip arthroplasty in dogs. Am J Vet Res 57: 720-723.
34. Petty W, Spanier S, Shuster JJ (1988) Prevention of infection after total joint replacement. Experiments with a canine model. J Bone Joint Surg Am 70: 536-539.
35. Alt V, Bitschnau A, Osterling J, Sewing A, Meyer C, Kraus R, et al. (2006) The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 27: 4627-4634.
36. Craig MR, Poelstra KA, Sherrell JC, Kwon MS, Belzile EL, et al. (2005) A novel total knee arthroplasty infection model in rabbits. J Orthop Res 23: 1100-1104.
37. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Cremieux AC, et al. (2002) Evaluation of (99 m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med 43: 239-245.
38. Belmatoug N, Cremieux AC, Bleton R, Volk A, Saleh-Mghir A, et al. (1996) A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis 174: 414-417.
39. Darouiche RO, Mansouri MD, Zakarevicz D, Alsharif A, Landon GC (2007) In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg Am 89: 792-797.
40. Moojen DJ, Vogely HC, Fleer A, Verbout AJ, Castelein RM, et al. (2009) No efficacy of silver bone cement in the prevention of methicillin-sensitive Staphylococcal infections in a rabbit contaminated implant bed model. J Orthop Res 27: 1002-1007. 10.1002/jor.20854 [doi].
41. Moojen DJ, Vogely HC, Fleer A, Nikkels PG, Higham PA, et al. (2009) Prophylaxis of infection and effects on osseointegration using a tobramycinperiapatite coating on titanium implants-an experimental study in the rabbit. J Orthop Res 27: 710-716. 10.1002/jor.20808 [doi].
42. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, et al. (2003) Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32: 521-531. S8756328203000504 [pii].
43. Antoci V, Jr., Adams CS, Hickok NJ, Shapiro IM, Parvizi J (2007) Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res 461: 88-95.
44. Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, et al. (2006) MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24: 79-91.
45. Miller LS, Pietras EM, Uricchio LH, Hirano K, Rao S, et al. (2007) Inflammasome-Mediated Production of IL-1beta Is Required for Neutrophil Recruitment against Staphylococcus aureus In Vivo. J Immunol 179: 6933-6942.
46. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, et al. (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 120: 1762-1773. 40891 [pii];10.1172/JCI40891 [doi].
47. Kim MH, Liu W, Borjesson DL, Curry FR, Miller LS, et al. (2008) Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J Invest Dermatol 128: 1812-1820.
48. Kim MH, Curry FR, Simon SI (2009) Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol 296: C848-C856. 00520.2008 [pii];10.1152/ajpcell. 00520.2008 [doi].
49. Bragg B, Epstein NJ, Ma T, Goodman S, Smith RL (2008) Histomorphometric analysis of the intramedullary bone response to titanium particles in wild-type and IL-1R1 knock-out mice: a preliminary study. J Biomed Mater Res B Appl Biomater 84: 559-570.
50. Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, et al. (2005) Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particleinduced inflammation. J Orthop Res 23: 501-510.
51. Antoci V, Jr., King SB, Jose B, Parvizi J, Zeiger AR, Wickstrom E, et al. (2007) Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 25: 858-866.
52. Hansen LK, Brown M, Johnson D, Palme Ii DF, Love C, et al. (2009) In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices. Pacing Clin Electrophysiol 32: 898-907.PACE2406 [pii];10.1111/j.1540-8159.2009.02406.x [doi].
53. Stoodley P, Nistico L, Johnson S, Lasko LA, Baratz M, et al. (2008) Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report. J Bone Joint Surg Am 90: 1751-1758. 90/8/1751 [pii];10.2106/JBJS.G.00838 [doi].
54. Sheehan E, McKenna J, Mulhall KJ, Marks P, McCormack D (2004) Adhesion of Staphylococcus to orthopaedic metals, an in vivo study. J Orthop Res 22: 39-43. S0736026603001529 [pii];10.1016/S0736-0266(03)00152-9 [doi].
55. Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H (2006) Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 11: 46-50.10.1007/s00776-005-0968-7 [doi].
56. Lauderdale KJ, Malone CL, Boles BR, Morcuende J, Horswill AR (2010) Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J Orthop Res 28: 55-61. 10.1002/jor.20943 [doi].
57. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, et al. (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112: 1466-1477. 10.1172/JCI20365 [doi];112/10/1466 [pii].
58. Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. pp 7-11. 00003086-200508000-00003 [pii].
59. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52: 13-22. FIM357 [pii];10.1111/j.1574-695X.2007.00357.x [doi].
60. Engelsman AF, van der Mei HC, Francis KP, Busscher HJ, Ploeg RJ, et al. (2009) Real time noninvasive monitoring of contaminating bacteria in a soft tissue implant infection model. J Biomed Mater Res B Appl Biomater 88: 123-129. 10.1002/jbm.b.31158 [doi].
61. Li D, Gromov K, Soballe K, Puzas JE, O'Keefe RJ, et al. (2008) Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res 26: 96-105. 10.1002/jor.20452 [doi].
62. Sjollema J, Sharma PK, Dijkstra RJ, van Dam GM, van der Mei HC, et al. (2010) The potential for bio-optical imaging of biomaterial-associated infection in vivo. Biomaterials 31: 1984-1995. S0142-9612(09)01312-X [pii];10.1016/j.biomaterials.2009.11.068 [doi].
63. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME (2006) Identification of Staphylococcus aureus proteins recognized by the antibodymediated immune response to a biofilm infection. Infect Immun 74: 3415-3426. 74/6/3415 [pii];10.1128/IAI.00392-06 [doi]